assessed the effect of SLC5A8 expression on the survival outcomes of patients with pancreatic cancer and found that low expression and nuclear translocation of SLC5A8 were associated with a poor prognosis.42 This evidence concerns the gene SLC5A8 and familial pancreatic carcinoma.